Biologically Active Caffeic Acid-Derived Biopolymer
Authors: V. Barbakadze, L. Gogilashvili, L. Amiranashvili, M. Merlani, K. Mulkijanyan
Abstract:
The high-molecular water-soluble preparations from several species of two genera (Symphytum and Anchusa) of Boraginaceae family Symphytum asperum, S. caucasicum, S.officinale and Anchusa italica were isolated. According to IR, 13C and 1H NMR, APT, 1D NOE, 2D heteronuclear 1H/13C HSQC and 2D DOSY experiments, the main chemical constituent of these preparations was found to be caffeic acid-derived polyether, namely poly[3-(3,4-dihydroxyphenyl)glyceric acid] (PDPGA) or poly[oxy-1- carboxy-2-(3,4-dihydroxyphenyl)ethylene]. Most carboxylic groups of this caffeic acid-derived polymer of A. italica are methylated.
Keywords: Anchusa, poly[3-(3, 4-dihydroxyphenyl)glyceric acid], poly[oxy-1-carboxy-2-(3, 4-dihydroxyphenyl)ethylene], Symphytum.
Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1109391
Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1427References:
[1] V. Barbakadze, E. Kemertelidze, I. Targamadze, K. Mulkijanyan, A. S. Shashkov, and A. I. Usov, ”Poly(3-(3,4-dihydroxyphenyl)glyceric acid), a new biologically active polymer from Symphytum asperum Lepech. and S.caucasicum Bieb. (Boraginaceae)”, Molecules, vol. 10, no. 9, pp. 1135-1144, Sept. 2005.
[2] V. Barbakadze, A. J. J. van den Berg, C. J. Beukelman, J. Kemmink, and H.C. Quarles van Ufford, “Poly(3-(3,4-dihydroxyphenyl)glyceric acid) from Symphytum officinale roots and its biological activity”, Chem. Nat. Compds., vol. 45, no. 1, pp. 6-10, January-February 2009.
[3] V. Barbakadze, L. Gogilashvili, L. Amiranashvili, M. Merlani, K. Mulkijanyan, M. Churadze, A. Salgado, and B. Chankvetadze, “Poly(3-(3,4-dihydroxyphenyl)glyceric acid) from Anchusa italica roots”, Nat. Prod. Commun., vol. 5, no. 7, pp. 1091-1095, July 2010.
[4] V. Barbakadze, M. Merlani, L. Amiranashvili, L. Gogilashvili, and K. Mulkijanyan. “Study of poly(oxy-1-carboxy-2-(3,4- dihydroxyphenyl)ethylene) from Symphytum asperum, S.caucasicum, S.officinale, Anchusa italica by circular dichroism”, Bull. Georg. Natl. Acad. Sci., vol. 6, no. 1, pp. 143-146, January-April 2012.
[5] V. V. Barbakadze, E. P. Kemertelidze, K. G. Mulkijanyan, A. J .J. van den Berg, C. J. Beukelman, E. van den Worm, H. C. Quarles van Ufford, and A. I. Usov, “Antioxidant and anticomplementary activity of poly(3- (3,4-dihydroxyphenyl)glyceric acid) from Symphytum asperum and S. caucasicum”, Pharm. Chem. J., vol. 41, no 1, pp. 14-16, January 2007.
[6] C. M. Barthomeuf, E.Debiton, V.V.Barbakadze, and E.P.Kemertelidze. “Evaluation of the dietetic and therapeutic potential of a high molecular weight hydroxicinnamate-derived polymer from Symphytum asperum Lepech. Regarding its antioxidant, antilipoperoxidant, antiinflammatory, and cytotoxic properties”, J. Agric. Food Chem., vol. 49, no. 8, pp. 3942-3946, August 2001.
[7] V. Barbakadze, K. Mulkijanyan, L. Gogilashvili, L. Amiranashvili, M. Merlani, Zh. Novikova, and M. Sulakvelidze, “Allantoin- and pyrrolizidine alkaloids-free wound healing compositions from Symphytum asperum”, Bull. Georg. Natl. Acad. Sci., vol. 3, no. 1, pp. 159-164, January-April 2009.
[8] K. Mulkijanyan, V. Barbakadze, Zh. Novikova, M. Sulakvelidze, L. Gogilashvili, L. Amiranashvili, and M. Merlani, “Burn healing compositions from Caucasian species of comfrey (Symphytum L.)”, Bull. Georg. Natl. Acad. Sci., vol. 3, no. 3, pp. 114-117, September- December 2009.
[9] V. Barbakadze, K. Mulkijanyan, M. Merlani, L. Gogilashvili, L. Amiranashvili, and F. Vidal-Vanaclocha, “Effects of poly(3-(3,4- dihydroxyphenyl)glyceric acid) on the inflammatory response of tumoractivated hepatic sinusoidal endothelium”, Bull. Georg. Natl. Acad. Sci., vol. 2, no 3, pp. 108-112, July-September 2008.
[10] S. Shrotriya, G. Deep, K. Ramasamy, K. Raina, V. Barbakadze, M. Merlani, L. Gogilashvili, L. Amiranashvili, K. Mulkijanyan, K.Papadopoulos, C. Agarwal, and R. Agarwal. “Poly(3-(3, 4- dihydroxyphenyl) glyceric) acid from comfrey exerts anti-cancer efficacy against human prostate cancer via targeting androgen receptor, cell cycle arrest and apoptosis”, Carcinogenesis, vol. 33, no. 8, pp. 1572-1580, August 2012.